Data as of November 13, 2026
Amlodipine-Valsartan 5-320 mg
AMLODIPINE AND VALSARTAN
Brand: Amlodipine and Valsartan
Acquisition price (NADAC) is as of October 21, 2026. Medicaid reimbursement figures are from 2024, the most recent year in CMS's published claims data. The two are not contemporaneous — treat any comparison as directional, not exact.
Price per fill
NADAC (acquisition)
$15.29/ fill$0.35 / EA
Cost Plus Drugs (retail)
$15.09/ fill$0.35 / EA
FUL
$30.25/ fill$0.70 / EA
AMP
$17.29/ fill$0.40 / EA
Medicaid FFS
$31.92/ fill
Medicaid MCO
$30.76/ fill
Sources: cms/nadac:price-ladder · costplusdrugs/price-list · cms/ful:generic-ceiling · cms/sdud. Cost Plus prices as of 2026-11-13
What's in the reimbursement
Ingredient cost (43.5 units/fill)$15.29
Dispensing fee & other (state-fixed, not margin)$16.63
Total reimbursed per fill$31.92
The gap above stays roughly flat across drugs regardless of acquisition cost — that's the professional dispensing fee, a fixed per-fill amount the state pays every pharmacy, not a markup.
Medicaid volume backing this card: 6 fee-for-service states, 15 managed-care states.
Full methodology and source columns: /tools/drug-prices/methodology